Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol PR/IR for chronic severe low back pain intolerant to WHO Step III opioids
2009-010428-25Phase 3Completed
- Sponsor
- Grünenthal GmbH
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of tapentadol in chronic low back pain (CLBP), sponsored by Grünenthal GmbH. Primary endpoint: Responder rate 1. Started Jun 2009; status: completed.
02
Drugs
tapentadol
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on 2009-010428-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010428-25.